These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12014442)

  • 1. Effects of hibarimicins and hibarimicin-related compounds produced by Microbispora on v-Src kinase activity and growth and differentiation of human myeloid leukemia HL-60 cells.
    Cho SI; Fukazawa H; Honma Y; Kajiura T; Hori H; Igarashi Y; Furumai T; Oki T; Uehara Y
    J Antibiot (Tokyo); 2002 Mar; 55(3):270-8. PubMed ID: 12014442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of hibarimicins. III. Structures of new hibarimicin-related metabolites produced by blocked mutants.
    Igarashi Y; Kajiura T; Furumai T; Hori H; Higashi K; Ishiyama T; Uramoto M; Uehara Y; Oki T
    J Antibiot (Tokyo); 2002 Jan; 55(1):61-70. PubMed ID: 11918068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of hibarimicins. II. Elucidation of biosynthetic pathway by cosynthesis using blocked mutants.
    Kajiura T; Furumai T; Igarashi Y; Hori H; Higashi K; Ishiyama T; Uramoto M; Uehara Y; Oki T
    J Antibiot (Tokyo); 2002 Jan; 55(1):53-60. PubMed ID: 11918066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction inhibitors, hibarimicins, A, B, C, D and G produced by Microbispora. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties.
    Kajiura T; Furumai T; Igarashi Y; Hori H; Higashi K; Ishiyama T; Uramoto M; Uehara Y; Oki T
    J Antibiot (Tokyo); 1998 Apr; 51(4):394-401. PubMed ID: 9630861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assignment and stereocontrol of hibarimicin atropoisomers.
    Romaine IM; Hempel JE; Shanmugam G; Hori H; Igarashi Y; Polavarapu PL; Sulikowski GA
    Org Lett; 2011 Sep; 13(17):4538-41. PubMed ID: 21812391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction inhibitors, hibarimicins A, B, C, D and G produced by Microbispora. II. Structural studies.
    Hori H; Igarashi Y; Kajiura T; Furumai T; Higashi K; Ishiyama T; Uramota M; Uehara Y; Oki T
    J Antibiot (Tokyo); 1998 Apr; 51(4):402-17. PubMed ID: 9630862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells.
    Yokoyama A; Okabe-Kado J; Uehara Y; Oki T; Tomoyasu S; Tsuruoka N; Honma Y
    Leuk Res; 1996 Jun; 20(6):491-7. PubMed ID: 8709621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total synthesis of hibarimicinone, a v-Src tyrosine kinase inhibitor possessing the pseudo-dimer structure of tetracycline.
    Tatsuta K; Hosokawa S
    Chem Rec; 2014 Feb; 14(1):28-40. PubMed ID: 24734306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total syntheses of HMP-Y1, hibarimicinone, and HMP-P1.
    Liau BB; Milgram BC; Shair MD
    J Am Chem Soc; 2012 Oct; 134(40):16765-72. PubMed ID: 22970979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
    Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
    Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
    Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
    Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors.
    Kraker AJ; Hartl BG; Amar AM; Barvian MR; Showalter HD; Moore CW
    Biochem Pharmacol; 2000 Oct; 60(7):885-98. PubMed ID: 10974196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
    Sokoloski JA; Shyam K; Sartorelli AC
    Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
    Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
    Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine compounds as inhibitors of the src protein tyrosine kinase: screening of a combinatorial library of 1,4-benzodiazepines.
    Ramdas L; Bunnin BA; Plunkett MJ; Sun G; Ellman J; Gallick G; Budde RJ
    Arch Biochem Biophys; 1999 Aug; 368(2):394-400. PubMed ID: 10441393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
    Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular ATP-dependent suppression of proliferation and induction of differentiation of human HL-60 leukemia cells by distinct mechanisms.
    Conigrave AD; van der Weyden L; Holt L; Jiang L; Wilson P; Christopherson RI; Morris MB
    Biochem Pharmacol; 2000 Dec; 60(11):1585-91. PubMed ID: 11077040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.